Intelligent nanobots offer the promise of smart drug delivery systems for a variety of therapeutic applications. A promise that experts in the field believe will become a reality within the next 30-40 years.
But at MedImmune, we don’t think patients should have to wait.
That’s why our researchers actively collaborate and investigate new efforts to explore possible applications of nanobots within our oncology, respiratory, and CVRM therapeutic areas.
